Yue-Xing Tu (Yuexing Tu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Intensive Care Unit

Signaling Pathway

Long Noncoding Rna

Acute Kidney Injury

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaofan Zhang, Yinrong Xie, Ying Zhang, Tailong Lei, Longjie Zhou, Jiayao Yao, Lin Liu, Haiyang Liu, Jintao He, Yunsong Yu, Yue-Xing Tu, Xi Li
Evolution of ceftazidime-avibactam resistance driven by mutations in double-copy bla KPC-2 to bla KPC-189 during treatment of ST11 carbapenem-resistant Klebsiella pneumoniae . mSystems (2024)
Di-Wen Shou, Yi-Rong Li, Xiu-Juan Xu, Mu-Hua Dai, Wei Zhang, Xue Yang, Yue-Xing Tu
Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Di-Wen Shou, Yi-Rong Li, Xiu-Juan Xu, Mu-Hua Dai, Wei Zhang, Xue Yang, Yue-Xing Tu
Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Di-Wen Shou, Zi-Lin Yu, Jian-Biao Meng, Zhi-Zhen Lai, Li-Sha Pang, Mu-Hua Dai, Xue Yang, Yue-Xing Tu
Panax notoginseng Alleviates Sepsis-Induced Acute Kidney Injury by Reducing Inflammation in Rats. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Mao-Hua Cai, Xiao-Gang Xu, Shi-Li Yan, Ze Sun, Yin Ying, Bai-Kui Wang, Yue-Xing Tu
Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine. Scientific reports 8 (1) (2018)